AMRX: Amneal Pharmaceuticals Inc Kompaniya qiymatining sof foydaga nisbati

Amneal Pharmaceuticals, Inc. (AMRX) korporativ emblemasi va logotipi

Amneal Pharmaceuticals (AMRX) murakkab biosimilarlar segmentiga yo'nalishni o'zgartirish orqali generik dori vositalariga bo'lgan bozor bosimiga qarshi kurashmoqda. Nusxa olish qiyin bo'lgan dori vositalarini ishlab chiqish qobiliyati kompaniyaga yuqori marjalarni saqlab qolish imkonini beradi. Joriy P/E koeffitsiyenti narxlardagi manipulyatsiyalarni aniqlashga yordam beradi, 54.80 qiymati esa ushbu metrikaning muvozanatini aks ettiradi. Ushbu grafik endokrinologiya sohasiga kengayish va qarzlarning agressiv ravishda kamaytirilishi natijasida yuzaga kelgan o'sish potentsialini tasdiqlaydi.

AMRX Amneal Corp: Narx-foyda koeffitsiyenti 04.07.2022 - 17.11.2026 oraligʻida

Amneal Pharmaceuticals, Inc. (AMRX) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning har tomonlama tahlili:Amneal - AMRX
Amneal yetakchi tovari

Investorlar Amneal Pharmaceuticals (AMRX) kompaniyasining barqarorligini baholamoqda, bunda sof foydani beqarorlashtirishi mumkin bo'lgan Osiyodan xomashyo yetkazib berish zanjirining uzilishlari xavflari ko'rib chiqilmoqda. Kompaniyaning tarixiy P/E dinamikasini tahlil qilish orqali, geosiyosiy noaniqlik sharoitida biznesning past baholangan holatida "qiymat tuzog'i"ga tushmaslik uchun bozor joriy foydaning necha yillik qismiga haq to'lashga tayyorligini aniqlash mumkin.

Muhim raqobatchilar

HLN: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti KVUE (Kenvue Corp)|VRNA (Verona Pharma Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Jyong Biotech Limited MENS|Ligand (LGND) - Kapitalizatsiyaning foydaga nisbati|PRGO: Narx-foyda koeffitsiyenti|Alvotech SA - Bozor narxining sof foydaga nisbati|LQDA: P/E multiplikatori|Galapagos Genomics - Kompaniya qiymatining sof foydaga nisbati|ANIP (ANI Pharmaceuticals Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati mannkindcorp.com MNKD|Narxning foydaga nisbati Amphastar Pharmaceuticals, Inc. (AMPH)|PCRX (Pacira Pharmaceuticals) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori SPRY (ARS Pharmaceuticals Inc)|Bozor narxining sof foydaga nisbati TBPH (Theravance)|AQST - Narxning foydaga nisbati|scPharmaceuticals (SCPH) - Narx-foyda koeffitsiyenti|TECX: P/E multiplikatori|Narx-foyda multiplikatori TNXP|Narxning foydaga nisbati China SXT Pharmaceuticals, Inc.|EPRX: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori BHST|EXOZ - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori ORMP (oramed.com)|P/E multiplikatori enterabio.com ENTX|HYFT - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati ABVC BioPharma, Inc ABVC|CPIX: P/E multiplikatori|Quantum BioPharma Ltd - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti FGEN|Telomir Pharmaceuticals, Inc. - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori RANI|SNYR (Synergy CHC) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Rallybio RLYB|Lexaria Bioscience (LEXX) - Kapitalizatsiyaning foydaga nisbati|PULM - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Pheton Holdings PTHL|APM (Aptorum) - Narx-foyda koeffitsiyenti|Lyra Therapeutics, Inc. (LYRA) - P/E multiplikatori|IBO (impactbiomedinc.com) - P/E multiplikatori|TNFA (TNF Pharmaceuticals) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati cbdmd.com (YCBD)|Biznesning o‘zini qoplash muddati PainReform Ltd|P/E multiplikatori CYTO (Altamira Therapeutics Ltd.)|Lipella Pharmaceuticals (LIPO) - Kapitalizatsiyaning foydaga nisbati|OPTN - Narxning foydaga nisbati|Pieris Pharmaceuticals - Bozor narxining sof foydaga nisbati|PROC (Procaps Group) - Narx-foyda koeffitsiyenti|PTPI - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Qilian International Holding Group Limited|SLRN: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti TFFP (TFF Pharma)